SEATTLE, Feb. 25, 2026 /PRNewswire/ -- Valant, the leading provider of behavioral health EHR software, today announced expanded capabilities for its AI-powered clinical documentation tool, AI Notes ...

Several new guidance documents issued by the FDA are poised to significantly impact the rare disease development landscape.

Good afternoon, everyone, and welcome to the Caris Life Sciences Q4 2025 Earnings Call. My name is Dana, and I will be your coordinator today. Thank you. Earlier today, Caris Life Sciences released ...

This afternoon, we released financial results for the quarter and full year ended December 31, 2025, and recent corporate updates. The press release is available on the Investors section of our ...

FDA Approval for Pediatric Indication -- LINZESS received U.S. FDA approval in November 2025 for IBS-C patients aged 7-17, ...

Age related macular degeneration is diagnosed through eye examination. Ophthalmologists use retinal imaging and optical ...

Market set for 11.6% CAGR driven by sustainability push and circular economy adoption in medical device manufacturing - ...

Gene therapy has been successfully used to treat a number of diseases, including immune deficiencies, hereditary blindness, ...

Thank you, Eva, and thank you all for joining us this morning. Before turning to our fourth quarter results, I would like to ...

People are increasingly leaning into being emotional. You can use generative AI such as ChatGPT to be a logic-to-emotion ...

With the safety of gene therapies thrown into the spotlight by a series of FDA clinical holds, Astellas has said that an interim readout in a phase 1/2 trial of its Pompe disease candidate AT845 ...

I think you will see total product guidance; you will see some guidance potentially on quarters, we will have to see how our ...